Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Ian Geh"'
Autor:
Joanne D. Stockton, Louise Tee, Celina Whalley, Jonathan James, Mark Dilworth, Rachel Wheat, Thomas Nieto, S-CORT Consortium, Ian Geh, João D. Barros-Silva, Andrew D. Beggs
Publikováno v:
Radiation Oncology, Vol 16, Iss 1, Pp 1-12 (2021)
Abstract Background Pathological complete response (pathCR) in rectal cancer is beneficial, as up to 75% of patients do not experience regrowth of the primary tumour, but it is poorly understood. We hypothesised that the changes seen in the pre-treat
Externí odkaz:
https://doaj.org/article/e778f28ee9ec4faebfafc381306dd3be
Autor:
Helen Mohan, Mohammed Rabie, Ciaran Walsh, Deena Harji, Paul Sutton, Ian Geh, Ian Jackson, Emma Helbren, Martyn Evans, John T. Jenkins
Publikováno v:
Colorectal Disease.
Autor:
Husnain Shah, Mohamad Roji, Ozgul Ekmekcioglu, John Ayuk, Stacey Smith, Zaira Khan, Suzanne Vickrage, Joanne Kemp-Blake, Sian Humphries, Simon Hughes, Salvador Diaz-Cano, Mona Elshafie, Salil Karkhanis, Shishir Shetty, Ian Geh, Tahir Shah
Publikováno v:
Endocrine Abstracts.
Publikováno v:
Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and IrelandREFERENCES.
The impact of surgeon volume on 18-month unclosed ileostomy rates after rectal cancer surgery has not been fully explored. The aim of this study was to describe the effect of surgeon volume and evaluate factors predictive of an unclosed ileostomy.Pat
Autor:
David Sebag-Montefiore, Amy Downing, Duncan C. Gilbert, Ian Geh, C. Jacobs, Cressida Lorimer, Wanangwa Clara Namelo, Paul Shaw, Richard Adams, Rebecca Shakir, Chris A. Jones, Rebecca Muirhead, Rachel Cooper
Publikováno v:
International Journal of Radiation Oncology, Biology, Physics
Purpose Our purpose was to describe the patterns and predictors of treatment failure in patients receiving definitive chemoradiation therapy (CRT) for anal squamous cell carcinoma (ASCC), delivered using intensity modulated radiation therapy (IMRT).
Autor:
Ananda Nahar, Yasir S Elhassan, John Ayuk, Joanne Kemp-Blake, Hema Venkataraman, Suzanne Vickrage, Raghavendar Palani, Kishen R Patel, Shishir Shetty, Tahir Shah, Ian Geh, Stacey Smith
Publikováno v:
Journal of neuroendocrinologyREFERENCES. 34(4)
Long-acting somatostatin analogues (SSAs) are the most commonly used drugs in the management of neuroendocrine tumours (NETs) because of their ability to control symptoms and prolong survival. SSA use is associated with changes in glucose metabolism.
Autor:
Ananda Nahar, Raghavendar Palani, Hema Venkataraman, Shishir Shetty, Suzanne Vickrage, Kishen R Patel, Yasir S Elhassan, John Ayuk, Stacey Smith, Tahir Shah, Ian Geh, Joanne Kemp-Blake
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e388d09839b56fe459a1af9187910c5
https://doi.org/10.1111/jne.13064/v3/response1
https://doi.org/10.1111/jne.13064/v3/response1
Autor:
Rachel Wheat, João D. Barros-Silva, Andrew D Beggs, Celina Whalley, Mark P Dilworth, Jonathan James, Thomas Nieto, Ian Geh, Joanne D. Stockton, Louise Tee
Publikováno v:
Radiation Oncology (London, England)
Radiation Oncology, Vol 16, Iss 1, Pp 1-12 (2021)
Radiation Oncology, Vol 16, Iss 1, Pp 1-12 (2021)
Background Pathological complete response (pathCR) in rectal cancer is beneficial, as up to 75% of patients do not experience regrowth of the primary tumour, but it is poorly understood. We hypothesised that the changes seen in the pre-treatment biop
Autor:
Simon P Bach, Alexandra Gilbert, Kristian Brock, Stephan Korsgen, Ian Geh, James Hill, Talvinder Gill, Paul Hainsworth, Matthew G Tutton, Jim Khan, Jonathan Robinson, Mark Steward, Christopher Cunningham, Bruce Levy, Alan Beveridge, Kelly Handley, Manjinder Kaur, Natalie Marchevsky, Laura Magill, Ann Russell, Philip Quirke, Nicholas P West, David Sebag-Montefiore, Gina Brown, Peter Antonio, Alex Vince, Nick Hilken, Chakanaka Sidile, Adrian Wilcockson, Richard Peto, Tom Crosby, Brendan Moran, Julie Olliff, Katti Ashok, Simone Slawik, Andrew Smethurst, Rajaram Sripadam, Veena Tagore, Monica Terlizzo, Bearn Philip, Robert Davies, Susan Dodd, Sharadah Essapen, Pasha Nisar, Alexandra Stewart, Jonathan Trickett, Bansal Ashish, Peter Billings, Palanichamy Chandran, Conor Corr, Edward Favill, Simon Gollins, Peter Marsh, Andrew Maw, Rakha Neupane, Ramesh Rajagopal, Rachel Cooper, John Griffith, Paul Hatfield, Andy Lowe, Julian Ostrowski, Rhian Simpson, Richard Adams, Robert Bleehen, Michael Davies, Meleri Morgan, Darren Boone, Nicola Lacey, Ian Seddon, Bruce Sizer, Helen Stunell, Shaobin Wu, Maher Hadaki, Dominic Blunt, Susan Cleator, Ara Darzi, Robert Goldin, Paul Ziprin, Mike Dobson, Mark Pitt, Shabbir Susnerwala, Deborah Williamson, Georgina Howarth, Stephen Lee, Paul Wright, Tim Hoare, Alan Horgan, Fiona McDonald, Stephanie Needham, John Scott, Timothy Simmons, Debashis Biswas, James Hernon, Gaurav Kapur, Sandeep Kapur, James Sington, Christopher Speakman, William Stebbings, Stuart Williams, Madhavi Adusumalli, Anil Agarwal, David Borowski, Dharmendra Garg, Mohammed Hegab, Catherine Hobday, Veena Rao, Jyotsna Shrimankar, Mohamed Tabaqchali, David Wilson, Oliver Jones, Neil Mortensen, Andrew Slater, Aron Szuts, Lai Wang, Bryan Warren, Andrew Weaver, Mukhtar Ahmad, Julian Alexander, Maxine Flubacher, David Tarver, Suhail Baluch, Richard Beable, David Cowlishaw, Antony Higginson, Prokopios Vogiatzis, Neil Cruickshank, Howard Joy, David Peake, Ulises Zanetto, Mark Saunders, Arthur Sun-Myint, Mark Teo, Arthur Allan, John Glaholm, Mark Goldstein, Rahul Hejmadi, Gerald Langman, Dion Morton, Cyril Nelson, Deborah Tattersall, Stephen Falk, Robert Longman, Huw Roach, Jamshed Shabbir, Golda Shelley-Fraser, Michael Thomas, Neil Cripps, Yasser Haba, Guy Harris, Max Hookway, Jay Simson, Angela Skull, Tijani Umar
Publikováno v:
The Lancet. Gastroenterology & Hepatology
Summary Background Radical surgery via total mesorectal excision might not be the optimal first-line treatment for early-stage rectal cancer. An organ-preserving strategy with selective total mesorectal excision could reduce the adverse effects of tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0429cb08c4dbffa6cf68653420de5021
https://eprints.whiterose.ac.uk/170564/1/PIIS2468125320303332.pdf
https://eprints.whiterose.ac.uk/170564/1/PIIS2468125320303332.pdf
Autor:
Philipe Taniere, Salvador Diaz-Cano, Suzanne Vickrage, Tahir Shah, Stacey Smith, Mona Elshafie, Ian Geh, Sam J. Ford, Husnain Shah, John Ayuk, Bobby V.M. Dasari, Kirstie Lithgow, Hema Venkataraman, Joanne Kemp-Blake, Simon Hughes, Shishir Shetty, Sian Humphries, Max Almond
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
Neuroendocrine neoplasms are known to have heterogeneous biological behavior. G3 neuroendocrine tumours (NET G3) are characterized by well-differentiated morphology and Ki67 > 20%. The prognosis of this disease is understood to be intermediate betwee